Pharmascience

1412 employees

Pharmascience is a manufacturer of generic drugs.

Investor insights

Sectors invested in

Pharmaceutical4

Biotechnology4

Health Care2

biotechnology1

BioPharmaceutical1

Clinical Trials1

Pharmaceutical Formulation Development1

Manufacturing1

Preformulation1

cGMP Manufacturing1

Tech Transfer1

Analytical Services1

Aseptic Manufacturing1

Biologics1

Therapeutics1

Medical1

Life Science1

Health Diagnostics1

KLH Protein (HMW and Subunit Formulations)1

Keyhole Limpet Hemocyanin (KLH) manufacture & sales1

Funding rounds participated in

$9.5M sweet spot round size

Most of their 5 investments are in rounds between $7M and $31M

Basic info

Industry

pharmaceutical manufacturing

Sectors

en vente libre et distribués par le pharmacien

000 products.

L’entreprise commercialise près de 300 familles de produits sous 20 formes de dosages distincts

Pharmaceutical

Pharmascience has been working through Health Partners International of Canada (HPIC) as a partner of choice to increase access to medicine. Pharmascience’s total donations of essential medicine is close to $70 million.

Depuis plus de 20 ans

Pharmascience inc. fabrique et commercialise des médicaments génériques vendus avec ordonnance

The company commercializes nearly 300 product families in 20 different dosage forms for over 2

behind-the-counter products as well as FDA approved Canadian-made injectables.

For more than 20 years

ainsi que des médicaments injectables fabriqués au Canada et approuvés par la Food and Drug Administration (FDA)

Pharmascience Inc. is a leading manufacturer and marketer of prescription generic

l’entreprise collabore avec Partenaires Canadiens pour la Santé Internationale (HPIC) dans le but d’aider l’organisme à accroître l’accès aux médicaments. La somme des médicaments essentiels offerts par Pharmascience inc. atteint à ce jour plus de 70 millions de dollars.

Manufacturing

Biopharma

ce qui représente plus de 2 000 produits.

over-the-counter

Date founded

1983

Investments made

RDD Pharma Ltd. raised $9.5M on November 16, 2017

Investors: Capital Point Ltd (CPTP), OrbiMed Advisors and Pharmascience

Stellar Biotechnologies, Inc. raised $7M on September 20, 2017

Investors: Inveready, Lumira Ventures and Pharmascience

Edesa Biotech raised $7M on September 20, 2017

Investors: Lumira Ventures, Inveready and Pharmascience

Pii (Pharmaceutics International, Inc.). raised $93M on September 6, 2016

Investors: Signet Healthcare Partners, Athyrium Capital Management, LP and Pharmascience

BIONPHARMA, INC. raised $31M on February 9, 2015

Investors: Signet Healthcare Partners and Pharmascience

Funding rounds raised

Total raised

$3.5M

from 1 investors over 1 rounds

Pharmascience raised $3.5M on May 16, 2011

Investors: Government of Canada (2 projects)